Zevia PBC (NYSE:ZVIA – Get Free Report) is anticipated to post its Q2 2026 results after the market closes on Wednesday, August 5th. Analysts expect the company to announce earnings of ($0.03) per share and revenue of $44.2070 million for the quarter. Parties can check the company’s upcoming Q2 2026 earning overview page for the latest details on the call scheduled for Wednesday, August 5, 2026 at 4:30 PM ET.
Zevia PBC (NYSE:ZVIA – Get Free Report) last released its quarterly earnings results on Wednesday, May 6th. The company reported ($0.03) earnings per share for the quarter, hitting analysts’ consensus estimates of ($0.03). Zevia PBC had a negative return on equity of 13.43% and a negative net margin of 4.11%.The firm had revenue of $46.09 million during the quarter, compared to analysts’ expectations of $40.97 million. On average, analysts expect Zevia PBC to post $-0 EPS for the current fiscal year and $-0 EPS for the next fiscal year.
Zevia PBC Stock Up 0.9%
Shares of NYSE:ZVIA opened at $1.59 on Wednesday. The company has a market capitalization of $122.78 million, a price-to-earnings ratio of -15.95 and a beta of 1.00. The company has a 50 day moving average of $1.57 and a two-hundred day moving average of $1.50. Zevia PBC has a 52-week low of $1.11 and a 52-week high of $3.63.
Insider Transactions at Zevia PBC
Institutional Investors Weigh In On Zevia PBC
Several hedge funds and other institutional investors have recently modified their holdings of ZVIA. Quadrature Capital Ltd acquired a new position in Zevia PBC in the fourth quarter worth $26,000. Engineers Gate Manager LP acquired a new stake in shares of Zevia PBC during the fourth quarter worth $28,000. The Manufacturers Life Insurance Company acquired a new stake in shares of Zevia PBC during the fourth quarter worth $38,000. Tocqueville Asset Management L.P. bought a new position in shares of Zevia PBC in the 3rd quarter worth about $44,000. Finally, JPMorgan Chase & Co. lifted its position in shares of Zevia PBC by 2,460.7% in the 2nd quarter. JPMorgan Chase & Co. now owns 15,518 shares of the company’s stock worth $50,000 after buying an additional 14,912 shares during the last quarter. Institutional investors own 53.21% of the company’s stock.
Analyst Ratings Changes
Separately, Weiss Ratings upgraded shares of Zevia PBC from a “sell (e+)” rating to a “sell (d-)” rating in a research note on Friday, July 17th. Three analysts have rated the stock with a Buy rating, two have assigned a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat.com, the stock currently has an average rating of “Hold” and a consensus target price of $4.42.
View Our Latest Stock Analysis on Zevia PBC
About Zevia PBC
Zevia PBC, headquartered in Los Angeles, is a Public Benefit Corporation that produces zero-calorie, naturally sweetened beverages. Founded in 2007, the company went public through a merger with a special purpose acquisition company in March 2021. Zevia’s mission centers on offering healthier drink alternatives by using stevia leaf extract and other plant-based ingredients rather than sugar or artificial sweeteners.
The company’s product portfolio spans multiple categories, including carbonated sodas, sparkling water, energy drinks, mixers and flavored teas.
Further Reading
- Five stocks we like better than Zevia PBC
- These 3 Stocks Have Soared in 2026—Can They Keep Climbing?
- Hasbro’s Earnings Beat Shows Why This Is No Longer Just a Toy Story
- Rambus: Another AI Phoenix Ready to Rise From the Ashes of Correction
- Chips & Clips: Memory Tariffs Rewire Tech Supply Chains
Receive News & Ratings for Zevia PBC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Zevia PBC and related companies with MarketBeat.com's FREE daily email newsletter.
